Zydus Lifesciences has received a clean report from the USFDA for its SEZ-II manufacturing facility in Ahmedabad, with the inspection concluding with no observations. The company’s board will meet on November 6 to consider raising up to ₹5,000 crore via various funding routes, alongside announcing its July–September quarter results.
